[
    [
        {
            "time": "",
            "original_text": "股价调整后是否再次上车机会？持续重点推荐药明康德、凯莱英等",
            "features": {
                "keywords": [
                    "股价调整",
                    "上车机会",
                    "药明康德",
                    "凯莱英"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "股价调整后是否再次上车机会？持续重点推荐药明康德、凯莱英等",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "招商证券时尚消费行业2021年中期投资策略：舸争流千帆竞 国货扬帆奋者先",
            "features": {
                "keywords": [
                    "招商证券",
                    "时尚消费",
                    "投资策略",
                    "国货"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "招商证券时尚消费行业2021年中期投资策略：舸争流千帆竞 国货扬帆奋者先",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "粤开证券首予华熙生物增持评级：华熙生物：护肤品业务持续走强，食品业务扬帄起航",
            "features": {
                "keywords": [
                    "粤开证券",
                    "华熙生物",
                    "护肤品",
                    "食品业务"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "美容",
                    "食品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "粤开证券首予华熙生物增持评级：华熙生物：护肤品业务持续走强，食品业务扬帄起航",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "浙商证券维持华熙生物买入评级，华熙生物21H1业绩预告点评：收入超预期，业绩全线向好",
            "features": {
                "keywords": [
                    "浙商证券",
                    "华熙生物",
                    "业绩预告",
                    "收入超预期"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "美容"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "浙商证券维持华熙生物买入评级，华熙生物21H1业绩预告点评：收入超预期，业绩全线向好",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "13股获买入评级 最新:百润股份",
            "features": {
                "keywords": [
                    "买入评级",
                    "百润股份"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "13股获买入评级 最新:百润股份",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【开源零售|周视角】多家美妆公司发布业绩预告，中报季序幕拉开",
            "features": {
                "keywords": [
                    "开源零售",
                    "美妆公司",
                    "业绩预告",
                    "中报季"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "零售",
                    "美妆"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【开源零售|周视角】多家美妆公司发布业绩预告，中报季序幕拉开",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "西部证券维持华熙生物买入评级，21H1业绩预告点评：收入超预期，多维驱动未来可期",
            "features": {
                "keywords": [
                    "西部证券",
                    "华熙生物",
                    "业绩预告",
                    "收入超预期",
                    "多维驱动"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "美容"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "西部证券维持华熙生物买入评级，21H1业绩预告点评：收入超预期，多维驱动未来可期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "半年报业绩预告陆续出炉！热景生物、东方生物、凯普生物…IVD企业业绩炸裂",
            "features": {
                "keywords": [
                    "半年报",
                    "业绩预告",
                    "热景生物",
                    "东方生物",
                    "凯普生物",
                    "IVD企业"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "半年报业绩预告陆续出炉！热景生物、东方生物、凯普生物…IVD企业业绩炸裂",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]